DR. RANDALL BROWN MD, MS
Prescription History 1124516398
Psychiatry & Neurology - Neurology in Stanford, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. RANDALL BROWN MD, MS, an active Neurology specialist practicing in Stanford, CA. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 125 documented patient claims. Among these therapy options, the most frequently utilized medication is Memantine Hcl, which accounts for 26 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Memantine Hcl | 26 | $17.39▼ below CA avg | ▼ Less than typical |
About Memantine Hcl: Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease. AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent. In 2024, this provider wrote 26 Medicare prescriptions for Memantine Hcl, about half the volume of the typical California prescriber of this medication (56.2). Medicare paid an average of $17.39 per fill, versus $29.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 43 30-Day Fills standardized to 30-day supplies 1,276 Days of Medication total across all patients in 2024 | |||
| Levetiracetam | 19 | $30.22▼ below CA avg | ▼ Less than typical |
About Levetiracetam: Levetiracetam is used to treat seizures (epilepsy). Show more ▾ It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have. A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent. In 2024, this provider wrote 19 Medicare prescriptions for Levetiracetam, about a third of the volume of the typical California prescriber of this medication (46.6). Medicare paid an average of $30.22 per fill, versus $37.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 43 30-Day Fills standardized to 30-day supplies 1,290 Days of Medication total across all patients in 2024 | |||
| Lamotrigine | 16 | $27.77 | ▼ Less than typical |
About Lamotrigine: Lamotrigine is used alone or with other medications to prevent and control seizures. Show more ▾ It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections). A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. In 2024, this provider wrote 16 Medicare prescriptions for Lamotrigine, about a third of the volume of the typical California prescriber of this medication (39.4). Medicare paid an average of $27.77 per fill, versus $14.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31.1 30-Day Fills standardized to 30-day supplies 934 Days of Medication total across all patients in 2024 | |||
| Carbidopa-LevodopaCarbidopa/Levodopa | 15 | $17.76▼ below CA avg | ▼ Less than typical |
About Carbidopa-Levodopa: This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Show more ▾ Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting. In 2024, this provider wrote 15 Medicare prescriptions for Carbidopa-Levodopa, about a quarter of the volume of the typical California prescriber of this medication (67.9). Medicare paid an average of $17.76 per fill, versus $38.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 28 30-Day Fills standardized to 30-day supplies 800 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 15 | $14.18▼ below CA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 15 Medicare prescriptions for Gabapentin, about 19% of the volume of the typical California prescriber of this medication (80.2). Medicare paid an average of $14.18 per fill, versus $15.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 25.1 30-Day Fills standardized to 30-day supplies 707 Days of Medication total across all patients in 2024 | |||
| Donepezil Hcl | 12 | $9.78▼ below CA avg | ▼ Less than typical |
About Donepezil Hcl: Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. Show more ▾ It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain. An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE. In 2024, this provider wrote 12 Medicare prescriptions for Donepezil Hcl, about a quarter of the volume of the typical California prescriber of this medication (58.4). Medicare paid an average of $9.78 per fill, versus $12.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 27.5 30-Day Fills standardized to 30-day supplies 825 Days of Medication total across all patients in 2024 | |||
| Divalproex Sodium | 11 | $65.47 | ▼ Less than typical |
About Divalproex Sodium: This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. Show more ▾ It works by restoring the balance of certain natural substances (neurotransmitters) in the brain. A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. In 2024, this provider wrote 11 Medicare prescriptions for Divalproex Sodium, about a quarter of the volume of the typical California prescriber of this medication (47.8). Medicare paid an average of $65.47 per fill, versus $38.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Propranolol Hcl | 11 | $15.60▼ below CA avg | ▼ Less than typical |
About Propranolol Hcl: This medication is a beta blocker used to treat high blood pressure, irregular heartbeats, shaking (tremors), and other conditions. Show more ▾ It is used after a heart attack to improve the chance of survival. It is also used to prevent migraine headaches and chest pain (angina). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Preventing chest pain can help improve your ability to exercise. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This effect reduces heart rate, blood pressure, and strain on the heart. A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. In 2024, this provider wrote 11 Medicare prescriptions for Propranolol Hcl, about half the volume of the typical California prescriber of this medication (25.4). Medicare paid an average of $15.60 per fill, versus $20.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 19 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. RANDALL BROWN MD, MS is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology prescribing approach at this Stanford, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
